Cannvas MedTech (CSE:MTEC) (“Cannvas” or the “Company”), a leading business technology company in the cannabis space, is pleased to announce its intent, operating under its newly-formed Cannvas Cannabis Acquisitions brand, to create a network of high-tech learning and fulfillment centres across Canada, improving accessibility to free and unbiased education about the potential benefits of medical and adult-use cannabis while providing curious consumers with on-site retail options from leading cannabis brands. Operating under the brand Cannvas Marché, each location will feature on-site medical and educational staff, digital learning resources and a fulfillment program, with the first centre expected to open in Toronto in early 2019.

“This is an exciting venture unlike anything being done in today’s market, benefitting active and potential medical and adult-use cannabis users by improving accessibility to free cannabis education while providing visitors to the centre with the opportunity for immediate fulfillment on-site,” said Steve Loutskou, Chief Operating Officer of Cannvas MedTech Inc and Chief Executive Officer of Cannvas Cannabis Acquisitions. “Our hope is that anyone of legal age will be able to visit their local Cannvas Marché, sit in on seminars pertaining to their lifestyle, speak with a health practitioner and, if they choose, interact with one of our retail partners to purchase cannabis products suited to their needs.”

Initial renderings for the Cannvas Marché concept are available at and the Company has entered into a Memorandum of Understanding (MOU) with a leading finance incubator of licensed cannabis ventures as its strategic realtor to advise on viability of certain locations in the city’s downtown core for the first cannabis education and fulfillment centre. Each centre will feature hands-on education sessions on a variety of cannabis-related topics with no pressure to purchase or consume. Sessions will be led by a registered health practitioner or certified educator and showcase original physician-backed content created for the Cannvas.Me platform. Visitors can register for free seminars each week or drop in anytime to access the content on their own through tablets and touch-screens.

“It’s never easy being the first to do anything and we believe strongly in the mission of our Cannvas Marché concept to provide accessible and unbiased cannabis education to consumers at all stages of cannabis curiosity while ensuring the overall long-term viability of this learning and retail hub,” said Shawn Moniz, Chief Executive Officer of Cannvas MedTech. “We have worked diligently to evaluate all potential revenue streams and are pleased with our projections both in the short- and long-term, and look forward to bringing our network of strategic partners into this project should there be a fit.”

The unique aspect of the Cannvas Marché is its fulfillment aspect. Each centre will include a retail marketplace component featuring leading cannabis brands ready to fulfill the needs of consumers wishing to purchase cannabis products. The proprietary retail business model Cannvas has developed ensures the Company remains true to its mission of remaining unbiased and offering content with no hidden agenda. Cannvas has already engaged several brands and are in discussions to issue Letters of Intent (LOIs) in the near future.

“We’re taking what Apple does with its Genius Bar and learning seminars and applying it to the cannabis retail experience to offer Canadians a value-added educational experience as they explore the world of legalized cannabis,” said Daniel Davidzon, Marketing Manager for Cannvas MedTech Inc. “In taking the same approach to a bricks-and-mortar location as we do online, we’re able to offer visitors to our Cannvas Marché centres unparalleled access to reliable and relevant information, arming them with the knowledge they need to be confident in taking the next steps in their cannabis journey while adding value with an immediate option for fulfillment.”

Cannvas is currently engaging with top regulators and compliance bodies as it works aggressively to begin the first phase of creating this first-of-its-kind public cannabis education and fulfillment centre. Through a creative licensing model, the Company intends to expand the reach of its Cannvas Marché centres to communities across Canada and use its strategic partnerships to further integrate the Cannvas.Me platform into existing retail experiences.

The project speaks to the strengths of the Cannvas executive team and its wealth of experience across a range of sectors. Steve Loutskou, COO of Cannvas MedTech Inc and CEO of Cannvas Cannabis Acquisitions, brings a successful track record in real estate and technology while Shawn Moniz, CEO at Cannvas MedTech has an extensive background in pharmacy and experiential patient education. Cannvas has also retained Nick Pavlov as its real estate advisor to vet properties in downtown Toronto. A past member of the Diversity Task Force and panel member (professional standards) for the Toronto Real Estate Board, Nick supplies real estate and market guidance within the retail and commercial sphere for cannabis-based activities, has represented three of Canada’s chartered banks as their selling specialist and has appeared in media on HGTV, Global TV, CBC and various print outlets.

About Cannvas Cannabis Acquisitions

Cannvas Cannabis Acquisitions is a wholly-owned subsidiary of Cannvas MedTech Inc., with a focus on investment and acquisition in the expanding global cannabis sector. Cannvas Cannabis seeks to complement Cannvas’ current product offering through continuous development, strategic investments and acquisitions in the cannabis sector. Related companies may include, but are not limited to technology, marketing and design, food and nutraceuticals, regulation and enforcement, new product development, gear and paraphernalia, retail stores and dispensaries, and testing labs.

About Cannvas MedTech Inc.

Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted

Click here to connect with Cannvas MedTech (CSE:MTEC) for an Investor Presentation.


Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”) , a leading international provider of consumer products in cannabis, today reported its financial and operating results for the first quarter ended March 31, 2021 . All financial information is provided in U.S. dollars unless otherwise indicated.

1Q 2021 Financial Highlights (Unaudited)

Keep reading... Show less

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Harvest Health & Recreation Inc. (“Harvest” or the “Company”) (OTC: HRVSF) in connection with the proposed acquisition of the Company by Trulieve Cannabis Corp. (“Trulieve”) (OTC: TCNNF). Under the terms of the merger agreement, Harvest shareholders will receive 0.1170 shares of Trulieve common stock for each Harvest share that they own, representing implied per-share merger consideration of approximately $4.79 based upon Trulieve’s May 7, 2021 closing price of $40.92 . Upon consummation of the transaction, current Harvest shareholders will own only 26.7% of the issued and outstanding pro forma Trulieve shares.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at Canaccord Genuity’s 5th Annual Global Cannabis Conference on Tuesday, May 11, 2021 at 2:30 p.m. EDT.

Participants may access a live webcast of the presentation by going to the Upcoming Events page at . A replay will be made available shortly following the live presentation.

Keep reading... Show less

Numinus and Multidisciplinary Association for Psychedelic Studies collaboration
will conduct follow-on Compassionate Access trial in real-world setting in Vancouver, Canada

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today congratulates the Multidisciplinary Association for Psychedelic Studies (MAPS) and the MAPP1 trial study team for their announcement of results from the Phase 3 randomized clinical trial of MDMA-assisted therapy for the treatment of severe post-traumatic stress disorder (PTSD).

Keep reading... Show less

Combined Company Will Maintain Industry Leading Scale in Retail, Cultivation & Production

Footprint Provides National Scale with a Deep Regional Focus in Attractive Markets

Keep reading... Show less